WO2012149472A9 - Methods, compositions, and kits for treating and preventing neurological conditions - Google Patents
Methods, compositions, and kits for treating and preventing neurological conditions Download PDFInfo
- Publication number
- WO2012149472A9 WO2012149472A9 PCT/US2012/035660 US2012035660W WO2012149472A9 WO 2012149472 A9 WO2012149472 A9 WO 2012149472A9 US 2012035660 W US2012035660 W US 2012035660W WO 2012149472 A9 WO2012149472 A9 WO 2012149472A9
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- kits
- compositions
- treating
- methods
- neurological conditions
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
- A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
- C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/156—Polymorphic or mutational markers
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201161479637P | 2011-04-27 | 2011-04-27 | |
| US61/479,637 | 2011-04-27 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| WO2012149472A2 WO2012149472A2 (en) | 2012-11-01 |
| WO2012149472A9 true WO2012149472A9 (en) | 2013-01-03 |
Family
ID=47073109
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PCT/US2012/035660 WO2012149472A2 (en) | 2011-04-27 | 2012-04-27 | Methods, compositions, and kits for treating and preventing neurological conditions |
Country Status (1)
| Country | Link |
|---|---|
| WO (1) | WO2012149472A2 (en) |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US11684609B2 (en) | 2013-08-19 | 2023-06-27 | The Regents Of The University Of California | Compounds and methods for treating an epileptic disorder |
Families Citing this family (22)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN113512522A (en) | 2013-03-15 | 2021-10-19 | 普林斯顿大学理事会 | Method and apparatus for high throughput purification |
| WO2016019393A1 (en) | 2014-08-01 | 2016-02-04 | Gpb Scientific, Llc | Methods and systems for processing particles |
| WO2014145152A2 (en) | 2013-03-15 | 2014-09-18 | Gpb Scientific, Llc | On-chip microfluidic processing of particles |
| WO2014144907A1 (en) * | 2013-03-15 | 2014-09-18 | Children's Medical Center Corporation | Methods and compounds for the treatment of dystroglycanopathies |
| WO2015092460A1 (en) * | 2013-12-18 | 2015-06-25 | INSERM (Institut National de la Santé et de la Recherche Médicale) | New gene mutations for the diagnosis of arthrogryposis multiplex congenita and congenital peripheral neuropathies disease |
| WO2015184279A1 (en) * | 2014-05-30 | 2015-12-03 | The Johns Hopkins University | Compositions and methods for treating kabuki syndrome and related disorders |
| WO2016014794A1 (en) * | 2014-07-25 | 2016-01-28 | Sangamo Biosciences, Inc. | Methods and compositions for modulating nuclease-mediated genome engineering in hematopoietic stem cells |
| DK3666258T3 (en) | 2014-09-19 | 2024-02-05 | Ferring Bv | PROCEDURE FOR THE TREATMENT OF PRADER-WILLI SYNDROME |
| CN108135987A (en) * | 2015-10-05 | 2018-06-08 | 范斯坦医药研究院 | Inhibit autism-spectrum obstacle using the bait antigen for source of parents Brain function antibody |
| EP3535407B1 (en) * | 2016-11-04 | 2021-06-02 | Qiagen Sciences, LLC | Thiol-containing cleave reagents and oxidative wash |
| US11103549B2 (en) | 2016-12-22 | 2021-08-31 | Asddr, Llc | Use of histone methyltransferase inhibitors and histone deacetylase inhibitors for therapy of Phelan-McDermid Syndrome |
| WO2018156883A1 (en) * | 2017-02-23 | 2018-08-30 | Board Of Regents, The University Of Texas System | Methods of treatment for cancer, sterol homeostasis, and neurological diseases |
| CN110891982B (en) | 2017-04-17 | 2023-12-22 | 芝加哥大学 | Polymeric materials for delivering short chain fatty acids to the intestinal tract for human health and disease treatment |
| EP3479845A1 (en) * | 2017-11-06 | 2019-05-08 | Stalicla S.A. | Challenge test for diagnosing subtype of autism spectrum disease |
| WO2019210080A1 (en) * | 2018-04-25 | 2019-10-31 | The Regents Of The University Of California | Methods and compositions for skeletal and neurological disorders |
| JP2022501440A (en) | 2018-09-20 | 2022-01-06 | リーヴォ セラピューティクス， インコーポレイテッド | Carbetocin drug and its manufacturing process |
| JP2021529220A (en) | 2018-09-20 | 2021-10-28 | リーヴォ セラピューティクス， インコーポレイテッド | Stable intranasal preparation of carbetocin |
| RU2733713C1 (en) * | 2020-02-11 | 2020-10-06 | Федеральное государственное бюджетное образовательное учреждение высшего образования "Воронежский государственный медицинский университет им. Н.Н. Бурденко" Министерства здравоохранения Российской Федерации | Method for predicting effectiveness of behavioural disorders in children with autism with gluten-free diet compliance |
| RU2726799C1 (en) * | 2020-02-11 | 2020-07-15 | Федеральное государственное бюджетное образовательное учреждение высшего образования "Воронежский государственный медицинский университет им. Н.Н. Бурденко" Министерства здравоохранения Российской Федерации | Method for prediction of the effectiveness of gastroenterological disorders correction in children with autism spectrum disorders |
| US20230321063A1 (en) * | 2020-08-20 | 2023-10-12 | Seattle Children's Hospital D/B/A Seattle Children's Research Institute | Compositions and methods to reduce neuroinflammation |
| WO2022058405A2 (en) * | 2020-09-16 | 2022-03-24 | Ifom - Istituto Firc Di Oncologia Molecolare | Histone deacetylase inhibitors and uses thereof |
| CA3196923A1 (en) * | 2020-09-30 | 2022-04-07 | Baylor College Of Medicine | Oxytocin treatment for hypermobile ehlers-danlos syndrome |
-
2012
- 2012-04-27 WO PCT/US2012/035660 patent/WO2012149472A2/en active Application Filing
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US11684609B2 (en) | 2013-08-19 | 2023-06-27 | The Regents Of The University Of California | Compounds and methods for treating an epileptic disorder |
Also Published As
| Publication number | Publication date |
|---|---|
| WO2012149472A2 (en) | 2012-11-01 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| WO2012149472A9 (en) | Methods, compositions, and kits for treating and preventing neurological conditions | |
| EP2773779A4 (en) | Methods and compositions for diagnosing, prognosing, and treating neurological conditions | |
| EP2714081A4 (en) | Methods, compositions, and kits for the treatment of cancer | |
| EP2895621A4 (en) | Methods and compositions for diagnosing, prognosing, and treating neurological conditions | |
| WO2011159945A9 (en) | Methods for treating neurological conditions | |
| GB2494845B (en) | Compositions and methods for treating automotive surfaces | |
| EP2542584B8 (en) | Methods for treating pancreatic cancer | |
| EP2684167A4 (en) | Compositions and methods useful for treating diseases | |
| EP2523944A4 (en) | Compounds and compositions for cognition-enhancement, methods of making, and methods of treating | |
| EP2664626A4 (en) | Modified conjugated diene rubber, method for producing same, and rubber composition | |
| WO2012054862A9 (en) | Agents, compositions, and methods for treating pruritis and related skin conditions | |
| WO2012088388A9 (en) | Treating multiple myeloma | |
| EP2830654B8 (en) | Methods and compositions for treating inflammation | |
| EP2729464B8 (en) | Cyclopropyl-fused-1,3-thiazepines as bace 1 and/or bace 2 inhibitors | |
| IL232710B (en) | L-serine compositions, methods and uses for treating neurodegenerative diseases and disorders | |
| EP2725901A4 (en) | Compositions, methods and kits for treating leukemia | |
| WO2011112588A9 (en) | Compositions and methods for treating inflammatory disorders | |
| WO2011137427A9 (en) | Compositions and methods for treating pulmonary conditions | |
| EP2775836B8 (en) | Methods for treating gout flares | |
| WO2012170720A3 (en) | Methods and compositions for treating brain cancer | |
| AP2013007056A0 (en) | Methods and compositions for treating kidney disorders | |
| WO2012068332A9 (en) | Methods for treating early stage or mild neurological disorders | |
| WO2011097577A9 (en) | Compositions and methods for treating or preventing retinal degeneration | |
| EP2723346A4 (en) | Compositions and methods useful for treating pediculosis | |
| WO2013025939A9 (en) | Compounds and methods for treating cancer by inhibiting the urokinase receptor |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| 121 | Ep: the epo has been informed by wipo that ep was designated in this application |
Ref document number: 12776891 Country of ref document: EP Kind code of ref document: A2 |
|
| NENP | Non-entry into the national phase |
Ref country code: DE |
|
| 122 | Ep: pct application non-entry in european phase |
Ref document number: 12776891 Country of ref document: EP Kind code of ref document: A2 |